Kidney Week

Oral Abstract Session

Late-Breaking Science Orals - 1

October 25, 2024 | 04:30 PM - 06:00 PM

Location: Room 6C, Convention Center

Session Description

Late-Breaking Science Oral Abstract Session

Learning Pathway(s)

• Other

Moderators

• David H. Ellison, MD, FASN
• Areef Ishani, MD, MS

Presentations

• Deferoxamine for the Prevention of Cardiac Surgery-Associated AKI: The DEFEAT-AKI Randomized Clinical Trial
  04:30 PM - 04:40 PM
  
  • David E. Leaf, MD, MS, MSc, FASN

Deferoxamine for the Prevention of Cardiac Surgery-Associated AKI: The DEFEAT-AKI Randomized Clinical Trial

October 25, 2024 | 04:30 PM - 04:40 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Effect of a Perioperative Hypotension Avoidance Strategy vs. a Hypertension Avoidance Strategy on the Risk of AKI
  04:40 PM - 04:50 PM
  
  • Amit X. Garg, MD, PhD

Effect of a Perioperative Hypotension Avoidance Strategy vs. a Hypertension Avoidance Strategy on the Risk of AKI

October 25, 2024 | 04:40 PM - 04:50 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Impact of Semaglutide on Infections and COVID-19: Data from the FLOW Trial
  04:50 PM - 05:00 PM
  
  • Brian Rayner, MBChB, PhD

Impact of Semaglutide on Infections and COVID-19: Data from the FLOW Trial

October 25, 2024 | 04:50 PM - 05:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Effect of Semaglutide on Mortality Outcomes in the FLOW Trial
  05:00 PM - 05:10 PM
  
  • Richard E. Pratley, MD

Effect of Semaglutide on Mortality Outcomes in the FLOW Trial

October 25, 2024 | 05:00 PM - 05:10 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Effects of 3.0 mEq/L [K+] Dialysate with Sodium Zirconium Cyclosilicate (SZC) vs. 2.0 mEq/L [K+] Dialysate without SZC on Cardiac Arrhythmia Rates
  05:10 PM - 05:20 PM
  
  • Wolfgang C. Winkelmayer, MD, ScD, MPH, FASN

Effects of 3.0 mEq/L [K+] Dialysate with Sodium Zirconium Cyclosilicate (SZC) vs. 2.0 mEq/L [K+] Dialysate without SZC on Cardiac Arrhythmia Rates

October 25, 2024 | 05:10 PM - 05:20 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Haemodiafiltration or Haemodialysis for Kidney Failure: Totality of Evidence Based on Individual Patient Data Meta-Analysis from Randomised Controlled Trials
  05:20 PM - 05:30 PM
  
  • Peter J. Blankestijn, MD, FASN

Haemodiafiltration or Haemodialysis for Kidney Failure: Totality of Evidence Based on Individual Patient Data Meta-Analysis from Randomised Controlled Trials

October 25, 2024 | 05:20 PM - 05:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Exploratory Post Hoc Analysis of the CONVINCE Randomized Controlled Trial: Differential Treatment Effects of Hemodiafiltration (HDF) and Hemodialysis (HD) on Quality of Life
  05:30 PM - 05:40 PM
  
  • Krister Cromm, MA, MS, MSc, MBA

Exploratory Post Hoc Analysis of the CONVINCE Randomized Controlled Trial: Differential Treatment Effects of Hemodiafiltration (HDF) and Hemodialysis (HD) on Quality of Life

October 25, 2024 | 05:30 PM - 05:40 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Varoglutamstat Increases Glomerular Filtration in Elderly Patients without Signs of Proteinuria and Potentially Offers a New Approach to Treat Diabetic Kidney Disease (DKD)
  05:40 PM - 05:50 PM
  
  • Frank Thomas Weber, DrMed

Varoglutamstat Increases Glomerular Filtration in Elderly Patients without Signs of Proteinuria and Potentially Offers a New Approach to Treat Diabetic Kidney Disease (DKD)

October 25, 2024 | 05:40 PM - 05:50 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: The PREPARE-iVAC Trial
  05:50 PM - 06:00 PM
  
  • A. Lianne Messchendorp, MD, PhD

Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: The PREPARE-iVAC Trial

October 25, 2024 | 05:50 PM - 06:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.